191 related articles for article (PubMed ID: 33684204)
1. The Impact of Increasing Disease Prevalence, False Omissions, and Diagnostic Uncertainty on Coronavirus Disease 2019 (COVID-19) Test Performance.
Kost GJ
Arch Pathol Lab Med; 2021 Jul; 145(7):797-813. PubMed ID: 33684204
[TBL] [Abstract][Full Text] [Related]
2. Designing and Interpreting Coronavirus Disease 2019 (COVID-19) Diagnostics: Mathematics, Visual Logistics, and Low Prevalence.
Kost GJ
Arch Pathol Lab Med; 2021 Mar; 145(3):291-307. PubMed ID: 32906146
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic Strategies for Endemic Coronavirus Disease 2019 (COVID-19).
Kost GJ
Arch Pathol Lab Med; 2022 Jan; 146(1):16-25. PubMed ID: 34551070
[TBL] [Abstract][Full Text] [Related]
4. The Coronavirus Disease 2019 Spatial Care Path: Home, Community, and Emergency Diagnostic Portals.
Kost GJ
Diagnostics (Basel); 2022 May; 12(5):. PubMed ID: 35626375
[TBL] [Abstract][Full Text] [Related]
5. The risk of over-diagnosis in serological testing. Implications for communications strategies.
Biggeri A; Forni S; Braga M
Epidemiol Prev; 2020; 44(5-6 Suppl 2):184-192. PubMed ID: 33412809
[TBL] [Abstract][Full Text] [Related]
6. Scaling up COVID-19 rapid antigen tests: promises and challenges.
Peeling RW; Olliaro PL; Boeras DI; Fongwen N
Lancet Infect Dis; 2021 Sep; 21(9):e290-e295. PubMed ID: 33636148
[TBL] [Abstract][Full Text] [Related]
7. Setting minimum clinical performance specifications for tests based on disease prevalence and minimum acceptable positive and negative predictive values: Practical considerations applied to COVID-19 testing.
Loh TP; Lord SJ; Bell K; Bohn MK; Lim CY; Markus C; Fares Taie H; Adeli K; Lippi G; Sandberg S; Horvath A
Clin Biochem; 2021 Feb; 88():18-22. PubMed ID: 33227233
[TBL] [Abstract][Full Text] [Related]
8. Test, test, test for COVID-19 antibodies: the importance of sensitivity, specificity and predictive powers.
Kumleben N; Bhopal R; Czypionka T; Gruer L; Kock R; Stebbing J; Stigler FL
Public Health; 2020 Aug; 185():88-90. PubMed ID: 32590234
[TBL] [Abstract][Full Text] [Related]
9. Rethinking COVID-19 test sensitivity-a strategy for improving the detection limit.
Akhtar MK; Leung RK; Khan G
Pan Afr Med J; 2021; 39():244. PubMed ID: 34659617
[TBL] [Abstract][Full Text] [Related]
10. Pragmatic Recommendations for the Use of Diagnostic Testing and Prognostic Models in Hospitalized Patients with Severe COVID-19 in Low- and Middle-Income Countries.
Schultz MJ; Gebremariam TH; Park C; Pisani L; Sivakorn C; Taran S; Papali A;
Am J Trop Med Hyg; 2021 Jan; 104(3_Suppl):34-47. PubMed ID: 33534752
[TBL] [Abstract][Full Text] [Related]
11. Ending the Pandemic: Are Rapid COVID-19 Tests a Step Forward or Back?
Zitek T; Fraiman JB
West J Emerg Med; 2021 May; 22(3):543-546. PubMed ID: 34125024
[TBL] [Abstract][Full Text] [Related]
12. Rapid coronavirus tests: a guide for the perplexed.
Guglielmi G
Nature; 2021 Feb; 590(7845):202-205. PubMed ID: 33564189
[No Abstract] [Full Text] [Related]
13. Specificity and positive predictive value of SARS-CoV-2 nucleic acid amplification testing in a low-prevalence setting.
Skittrall JP; Wilson M; Smielewska AA; Parmar S; Fortune MD; Sparkes D; Curran MD; Zhang H; Jalal H
Clin Microbiol Infect; 2021 Mar; 27(3):469.e9-469.e15. PubMed ID: 33068757
[TBL] [Abstract][Full Text] [Related]
14. Evaluating a SARS-CoV-2 screening strategy based on serological tests.
Baccini M; Mattei A; Rocco E; Vannucci G; Mealli F
Epidemiol Prev; 2020; 44(5-6 Suppl 2):193-199. PubMed ID: 33412810
[TBL] [Abstract][Full Text] [Related]
15. Impact of RT-PCR Test False-Negative Results for SARS-CoV-2 Surveillance in Mexico.
Núñez I; Belaunzarán-Zamudio PF; Caro-Vega Y
Rev Invest Clin; 2020 Dec; 73(2):120-6. PubMed ID: 33861544
[TBL] [Abstract][Full Text] [Related]
16. In vitro diagnostics of coronavirus disease 2019: Technologies and application.
Lai CC; Wang CY; Ko WC; Hsueh PR
J Microbiol Immunol Infect; 2021 Apr; 54(2):164-174. PubMed ID: 32513617
[TBL] [Abstract][Full Text] [Related]
17. Public's understanding of swab test results for SARS-CoV-2: an online behavioural experiment during the April 2020 lockdown.
Pighin S; Tentori K
BMJ Open; 2021 Jan; 11(1):e043925. PubMed ID: 33455939
[TBL] [Abstract][Full Text] [Related]
18. Clinical evaluation of a fully automated, laboratory-developed multiplex RT-PCR assay integrating dual-target SARS-CoV-2 and influenza A/B detection on a high-throughput platform.
Nörz D; Hoffmann A; Aepfelbacher M; Pfefferle S; Lütgehetmann M
J Med Microbiol; 2021 Feb; 70(2):. PubMed ID: 33404401
[No Abstract] [Full Text] [Related]
19. Multi-Platform Comparison of SARS-CoV-2 Serology Assays for the Detection of COVID-19.
Suhandynata RT; Hoffman MA; Kelner MJ; McLawhon RW; Reed SL; Fitzgerald RL
J Appl Lab Med; 2020 Nov; 5(6):1324-1336. PubMed ID: 32766840
[TBL] [Abstract][Full Text] [Related]
20. Multiplex Real-Time Reverse-Transcription Polymerase Chain Reaction Assays for Diagnostic Testing of Severe Acute Respiratory Syndrome Coronavirus 2 and Seasonal Influenza Viruses: A Challenge of the Phase 3 Pandemic Setting.
Mancini F; Barbanti F; Scaturro M; Fontana S; Di Martino A; Marsili G; Puzelli S; Calzoletti L; Facchini M; Di Mario G; Fabiani C; Bella A; Riccardo F; Pezzotti P; Stefanelli P; Rezza G; Ciervo A;
J Infect Dis; 2021 Mar; 223(5):765-774. PubMed ID: 33080031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
